Synthetic virus may lead to more effective smallpox vaccine
Team Udayavani, Jan 21, 2018, 4:17 PM IST
Toronto: Scientists have created a synthetic horsepox virus that could lead to the development of a more effective vaccine against smallpox. The discovery demonstrates how techniques based on the use of synthetic DNA can be used to advance public health measures.
Researchers from the University of Alberta in Canada produced an infectious horsepox virus, which they synthetically reconstructed using a published genome sequence and DNA fragments manufactured entirely by chemical methods.
The team went on to show that the synthetic horsepox virus could provide vaccine protection in a mouse model of poxvirus infection. “This application of synthetic DNA technology has the potential to revolutionise how we manufacture complex biologicals including recombinant viruses,” said David Evans, a professor at the University of Alberta.
“These methods advance the capacity to produce next-generation vaccines and offer special promise as a tool for constructing the complicated synthetic viruses that will likely be needed to treat cancer,” said Evans. The synthesised horsepox virus is the largest virus assembled to date using chemically synthesised DNA.
Horsepox – an equine disease caused by horsepox virus – is not a hazard to humans. It is closely related to vaccinia virus, the virus that was used as a vaccine to eradicate human smallpox 40 years ago. While there have been no cases of naturally occurring smallpox since 1977, it remains a concern to public health agencies
Current smallpox vaccines are used to protect first responders and military service members but are rarely used except in special circumstances. Due to the toxicity of most modern smallpox vaccines, Canada and the US have long discontinued immunising whole populations, as was the policy prior to smallpox eradication.
Researchers had previously used more traditional recombinant DNA technologies to engineer a vaccinia virus with the aim of improving the treatment for bladder cancer. The virus is an oncolytic virus, which means it was modified to selectively kill rapidly-dividing cancer cells while remaining safe for surrounding healthy cells.
In pre-clinical models, these viruses can infect and kill cancer cells while promoting the development of an immune response that is needed to prevent the cancer from returning. However, future generations of oncolytic viruses will require a greater degree of modification than is possible using older technologies. Synthetic biology offers a powerful tool for manufacturing these more complicated biological therapeutics.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
Study finds genetic basis for link between depression, heart disease
World Malaria Day: WHO calls for equitable health access
What role does genetics play in breast cancer? How can genetic testing help with early breast cancer diagnosis?
Father’s diet can affect anxiety in sons, metabolism in daughters: Study in mice finds
Low back pain, depression, headaches main causes of poor health: Study
MUST WATCH
Latest Additions
Patanjali Foods to evaluate proposal to buy Patanjali Ayurved’s non-food business
Congress to discuss candidates for Amethi, Raebareli seats on Saturday
BJP’s CT Ravi Booked for Promoting Hatred and Enmity Through Social Media Post
Elections held in 14 LS segments in Karnataka, voter turnout nearly 64 per cent till 5 pm
‘PM is scared, may even shed tears on stage’: Rahul Gandhi’s fresh salvo at Modi